Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors.

MLA

Breidenbach, Julian, et al. “Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors.” Angewandte Chemie International Edition, vol. 60, no. 18, Apr. 2021, pp. 10423–29. EBSCOhost, https://doi.org/10.1002/anie.202016961.

APA

Breidenbach, J., Lemke, C., Pillaiyar, T., Schäkel, L., Al Hamwi, G., Diett, M., Gedschold, R., Geiger, N., Lopez, V., Mirza, S., Namasivayam, V., Schiedel, A. C., Sylvester, K., Thimm, D., Vielmuth, C., Phuong Vu, L., Zyulina, M., Bodem, J., Gütschow, M., & Müller, C. E. (2021). Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors. Angewandte Chemie International Edition, 60(18), 10423–10429. https://doi.org/10.1002/anie.202016961

Chicago

Breidenbach, Julian, Carina Lemke, Thanigaimalai Pillaiyar, Laura Schäkel, Ghazl Al Hamwi, Miriam Diett, Robin Gedschold, et al. 2021. “Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors.” Angewandte Chemie International Edition 60 (18): 10423–29. doi:10.1002/anie.202016961.